Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled Trials

Figure 1

Flowchart of articles included in the meta-analysis. Articles that meet the inclusion requirements were screened according to PRISMA guidelines, and PICO principles were followed (population, interventions, comparisons, and outcomes).